Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2026-01-01 @ 8:15 PM
Study NCT ID:
NCT03732235
Status:
UNKNOWN
Last Update Posted:
2019-02-21
First Post:
2018-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Sponsor:
Giammaria Fiorentini
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-30
First Submit QC Date:
None
Study First Post Date:
2018-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-19
Last Update Post Date:
2019-02-21
Last Update Post Date Type:
ACTUAL